Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [21] Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Patients With Acute Pancreatitis; Progress or 'suPAR' Revolution in Predicting Acute Pancreatitis Outcome
    Lipinski, Michal
    Rydzewska-Rosolowska, Alicja
    Rydzewski, Andrzej
    Rydzewska, Grazyna
    GASTROENTEROLOGY, 2015, 148 (04) : S679 - S679
  • [22] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Bocskai, Marta
    Deak, Magdolna
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    BIOMARKERS, 2012, 17 (08) : 758 - 763
  • [23] Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
    Manfredi, Mariangela
    Van Hoovels, Lieve
    Benucci, Maurizio
    De Luca, Riccardo
    Coccia, Carmela
    Bernardini, Pamela
    Russo, Edda
    Amedei, Amedeo
    Guiducci, Serena
    Grossi, Valentina
    Bossuyt, Xavier
    Perricone, Carlo
    Infantino, Maria
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [24] A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells
    Mizukami, IF
    Todd, RF
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (02) : 203 - 213
  • [25] Usefulness of soluble urokinase plasminogen activator receptor (suPAR) as an inflammatory biomarker in obese children
    Kosecik, Mustafa
    Dervisoglu, Pinar
    Koroglu, Mehmet
    Isguven, Pinar
    Elmas, Bahri
    Demiray, Tayfur
    Altindis, Mustafa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 158 - 161
  • [26] Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
    Phuong Anh Le Thy
    Thuy Yen Hoang Thi
    Kiem Hao Tran
    Huu Son Nguyen
    Egyptian Pediatric Association Gazette, 70
  • [27] Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
    Hoybye, Charlotte
    Faseh, Laia
    Himonakos, Christos
    Pielak, Tomasz
    Eugen-Olsen, Jesper
    ENDOCRINE CONNECTIONS, 2019, 8 (06): : 772 - 779
  • [28] Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
    Oezdirik, Burcin
    Stueven, Anna
    Knorr, Jana
    Geisler, Lukas
    Mohr, Raphael
    Demir, Muenevver
    Hellberg, Teresa
    Loosen, Sven H.
    Benz, Fabian
    Wiedenmann, Bertram
    Tacke, Frank
    Wree, Alexander
    Jann, Henning
    Roderburg, Christoph
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [29] Soluble urokinase plasminogen activator receptor (suPAR) for monitoring inflammatory activity in rheumatic diseases
    Toldi, G.
    Szalay, B.
    Kadar, G.
    Bocskai, M.
    Deak, M.
    Kovacs, L.
    Vasarhelyi, B.
    Balog, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
  • [30] Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
    Klim, Sebastian M.
    Prattes, Juergen
    Amerstorfer, Florian
    Niedrist, Tobias
    Zurl, Christoph
    Stradner, Martin
    Dreo, Barbara
    Glehr, Gunther
    Leithner, Andreas
    Glehr, Mathias
    Reinbacher, Patrick
    Sadoghi, Patrick
    Hauer, Georg
    ANTIBIOTICS-BASEL, 2024, 13 (02):